Helix BioPharma Corp. (HBP.TO)

CAD 1.0

(5.26%)

Gross Profit Summary of Helix BioPharma Corp.

  • Helix BioPharma Corp.'s latest annual gross profit in 2024 was -14 Thousand CAD , down -7.69% from previous year.
  • Helix BioPharma Corp.'s latest quarterly gross profit in 2024 Q1 was -4000.00 CAD , down 0.0% from previous quarter.
  • Helix BioPharma Corp. reported a annual gross profit of -13 Thousand CAD in annual gross profit 2023, down -8.33% from previous year.
  • Helix BioPharma Corp. reported a annual gross profit of -12 Thousand CAD in annual gross profit 2022, up 93.06% from previous year.
  • Helix BioPharma Corp. reported a quarterly gross profit of -4000.00 CAD for 2024 Q1, down 0.0% from previous quarter.
  • Helix BioPharma Corp. reported a quarterly gross profit of -3000.00 CAD for 2024 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Helix BioPharma Corp. (2024 - 2007)

Historical Annual Gross Profit of Helix BioPharma Corp. (2024 - 2007)

Year Gross Profit Gross Profit Growth
2024 -14 Thousand CAD -7.69%
2023 -13 Thousand CAD -8.33%
2022 -12 Thousand CAD 93.06%
2021 -173 Thousand CAD 18.4%
2020 -212 Thousand CAD -278.57%
2019 -56 Thousand CAD 66.47%
2018 -167 Thousand CAD -28.46%
2017 -130 Thousand CAD 2.99%
2016 -134 Thousand CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD -100.0%
2012 2.51 Million CAD -12.84%
2011 2.89 Million CAD 4.52%
2010 2.76 Million CAD 18.92%
2009 2.32 Million CAD -1.15%
2008 2.35 Million CAD 2.93%
2007 2.28 Million CAD 0.0%

Peer Gross Profit Comparison of Helix BioPharma Corp.

Name Gross Profit Gross Profit Difference
Appili Therapeutics Inc. 813.74 Thousand CAD 101.72%
Eupraxia Pharmaceuticals Inc. -209.91 Thousand CAD 93.331%
Microbix Biosystems Inc. 7.48 Million CAD 100.187%
Medicenna Therapeutics Corp. -5000.00 CAD -180.0%
Satellos Bioscience Inc. -8.81 Million CAD 99.841%
Oncolytics Biotech Inc. -403 Thousand CAD 96.526%
Sernova Corp. -445.55 Thousand CAD 96.858%